XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholder's Equity (Tables)
12 Months Ended
Jul. 31, 2021
Equity [Abstract]  
Schedule of stock options exercised utilizing a cashless exercise
The exercised stock options, utilizing a cashless exercise, are summarized in the following table:
PeriodOptions ExercisedWeighted Average Exercise PriceShares Net Settled for Exercise
Shares Withheld for Taxes (1)
Net Shares to EmployeesWeighted Average Share Price for WithholdingEmployee Stock-Based Tax Withholding (in 000s)
FY 2019—Q33,000,000 $17.81 945,162 806,039 1,248,799 $56.53 $45,565 
FY 2020—Q14,000,000 17.81 865,719 1,231,595 1,902,686 82.29 101,348 
FY 2021—Q490,000 17.73 12,366 29,349 48,285 129.01 3,786 
(1)Shares withheld for taxes are treated as a repurchase of shares for accounting purposes but do not count against the Company’s stock repurchase program.
Schedule of share-based compensation expense
The table below sets forth the stock-based compensation recognized by the Company for stock options, restricted stock, and restricted unit awards:
Year Ended July 31,
(In thousands)202120202019
General and administrative$35,633 $17,567 $18,254 
Yard operations5,289 5,755 5,191 
Total stock-based compensation$40,922 $23,322 $23,445 
Schedule of non-vested shares
A summary of the status of the Company’s non-vested shares from stock option awards and its activity during the year ended July 31, 2021 was as follows:
(In thousands, except per share amounts)SharesWeighted
Average Grant-
date Fair Value
Non-vested shares at July 31, 20203,303 $17.58 
Grants of non-vested shares1,310 31.17 
Vested(1,139)16.65 
Forfeitures or expirations(213)12.84 
Non-vested shares at July 31, 20213,261 $22.80 
Schedule of option activity
The following is a summary of activity for the Company’s stock options for the year ended July 31, 2021:
(In thousands, except per share and term data)SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (In years)Aggregate Intrinsic Value
Outstanding as of July 31, 20208,059 $41.44 6.72$417,529 
Grants of options1,310 107.95 
Exercises(1,599)25.47 
Forfeitures or expirations(213)47.11 
Outstanding as of July 31, 20217,557 $56.19 6.53$686,269 
Exercisable as of July 31, 20214,295 $38.16 5.17$467,433 
Vested and expected to vest as of July 31, 20217,557 $56.19 6.52$686,269 
Schedule of stock options outstanding and exercisable
The following table summarizes stock options outstanding and exercisable as of July 31, 2021:
(In thousands, except per share amounts)Options OutstandingOptions Exercisable
Range of Exercise PricesNumberWeighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price
NumberWeighted
Average
Exercise
Price
$12.48$17.73890 3.25$16.72 890 $16.72 
$17.81$36.322,393 5.0628.16 1,988 26.68 
$43.96$58.271,740 7.1755.59 876 53.05 
$77.51$134.422,534 8.6296.93 541 91.47 
Outstanding as of July 31, 20217,557 6.53$56.19 4,295 $38.16 
Schedule of restricted stock activity
The following is a summary of activity for the Company’s RSA’s and RSU’s for the for the year ended July 31, 2021:
(In thousands, except per share data)Restricted SharesWeighted Average Grant Date Fair Value
Outstanding as of July 31, 2020105 $69.86 
Grants61 116.86 
Vested(58)83.26 
Forfeitures or expirations(6)67.55 
Outstanding as of July 31, 2021102 $90.46